Status:

RECRUITING

Long-term Longitudinal Imaging of Presynaptic Terminals in PD

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Conditions:

Parkinson Disease

Eligibility:

All Genders

30+ years

Phase:

NA

Brief Summary

AIM: To investigate whether SV2A loss spreads from brainstem to cerebral cortex with progression of Parkinson's disease (PD) and to determine whether longitudinal cortical SV2A loss correlates with co...

Eligibility Criteria

Inclusion

  • Participation in study S61477 (NCT04243304)

Exclusion

  • Neuropsychiatric diseases (unrelated to PD for PD patients)
  • Major internal medical diseases
  • History of alcohol or drug abuse
  • Relevant abnormalities on MR brain
  • Contraindications for MR
  • Pregnancy or breastfeeding
  • Previous participation in other research studies involving ionizing radiation with \> 1 mSv over past 12 months.

Key Trial Info

Start Date :

July 16 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2027

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT06875765

Start Date

July 16 2025

End Date

December 1 2027

Last Update

July 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UZ Leuven

Leuven, Belgium, 3000

Long-term Longitudinal Imaging of Presynaptic Terminals in PD | DecenTrialz